Gene Query: TNRC6A

Dataset Description Geneva Score
Knockdown of ADNP in HCT116 colon cancer cells 64.59
Altering cancer transcriptomes using epigenomic inhibitors 52.64
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 52.64
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 51.96
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 47.32
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 34.04
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 33.87
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 28.03
RNA-seq analysis of BAP1-depleted uveal melanoma cells 27.56
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 24.48
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 23.29
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 23.17
RNA sequencing of mechanically strained NHEKs and control NHEKs 22.53
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 22.34
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 22.34
TFAP2C signalling in human fibroblasts 22.3
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 22.22
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 21.3
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 21.17
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 21.17
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 19.86
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 19.35
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 19.1
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 18.92
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 18.9
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 18.73
Effect of BB608 on Gene Expression in HNSCC Cell Line 18.31
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 18.14
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 18.14
TCF7L1 knockdown in pancreatic cancer 18.13
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 18.05
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 17.71
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 16.58
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 15.95
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 15.64
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 15.62
Effect of from Human Umbilical Vein Endothelial Cells 15.48
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 15.32
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 15.18
LINE-2 transposable elements are a source of functional human microRNAs and target sites 15.0
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 14.94
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 14.57
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 14.56
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 14.23
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 14.23
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 14.14
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 14.14
Gene expression changes after LOC550643 silencing 14.12
miRNAs affected by antagomiR-17 treatment 14.08
Gene expressions of H9s in different culture systems 13.78
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 13.66
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 13.64
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 13.45
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 13.41
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 13.3
BASP1 modifies the Tamoxifen response 13.29
CD73 knockdown effect in pancreatic cancer cell lines 13.11
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 12.97
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 12.97
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 12.94
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 12.72
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 12.68
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 12.55
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 12.52
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 12.49
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 12.34
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 12.25
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 12.15
Landscape and variation of RNA secondary structure across the human transcriptome 12.06
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 12.04
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 12.03
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 11.91
The interplay between SOX4 and SMAD3 in the context of breast cancer 11.87
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 11.82
Genes significantly down or Up-regulated upon RNF219 knockdown 11.77
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 11.7
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 11.68
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 11.68
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 11.47
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 11.47
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 11.41
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 11.35
RNA-seq of naive and primed ES cells (NHSM) 11.23
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 11.18
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 11.08
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 11.02
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 11.0
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 10.98
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 10.97
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 10.95
Cerebellar differentiation in Ataxia-Telangiectasia 10.78
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 10.76
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 10.67
Identification of Nrf2 regulated genes by RNA sequencing 10.55
Nrf2 regulated genes in A549 cells 10.55
miR941 overexpression experiment 10.51
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 10.5
RNA-sequencing in irradiated and normal A549 cells. 10.49
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 10.35
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 10.31
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 10.28
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 10.28
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 10.27
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 10.27
Transcriptome analysis of U87 cells upon LINC00152 knockdown 10.27
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 10.21
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 10.14
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 9.96
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 9.94
JunB control of keratinocyte-mediated inflammation [RNA-seq] 9.94
Transcriptomic analysis of the HOTAIR-regulated genes 9.93
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 9.88
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 9.75
Effect of BMP inhibition or stimulation of primary human keratinocytes 9.74
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 9.74
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 9.74
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 9.72
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 9.69
Transcriptional profiling of microglia; current state of the art and future perspectives 9.66
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 9.6
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 9.59
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 9.58
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 9.58
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 9.51
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 9.5
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 9.41
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 9.39
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 9.33
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 9.33
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 9.25
RNA-Seq from early time points in the kidney differentiation protocol 9.21
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 9.12
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 9.11
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 9.1
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 9.08
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 9.08
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 9.02
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 8.93
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 8.93
DART-seq: an antibody-free method for global m6A detection 8.91
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 8.88
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 8.88
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 8.87
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 8.87
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 8.82
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 8.82
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 8.77
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 8.73
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 8.73
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 8.69
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 8.66
Zone dependent distinctive gene expression profile of the normal human liver tissue 8.6
EWSR1 influences alternative splicing through direct and indirect mechanisms 8.59
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 8.51
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 8.5
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 8.47
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 8.44
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 8.44
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 8.41
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 8.38
Genome wide miR-191 target profile determined by RIP and gene expression profiling 8.38
Global response to chemotherapy-induced apoptosis 8.29
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 8.28
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 8.28
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 8.25
Global Mapping of Human RNA-RNA Interactions 8.23
LncRNA expression profiling of ischemic stroke patients 8.2
Region-specific Innate Antiviral Responses of the Human Epididymis 8.16
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 8.15
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 8.15
Functional role of CPPED1 in trophoblasts. 8.09
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 8.09
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 8.08
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 8.07
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 8.06
Splicing and epigenetic factors jointly regulate epidermal differentiation 8.04
RNA polymerase in pre-B-ALL cell lines 8.04
The evolution of N6-methyladenosine in primates 8.03
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 8.03
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 8.02
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 8.02
Expression profiling of etoposide-induced senescent cells 8.0
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 7.98
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 7.96
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 7.96
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 7.94
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 7.9
Integrating single-cell transcriptomic data across different conditions, technologies, and species 7.87
Gene expression profile of human placenta from T. Cruzi infected mothers 7.86
R430: A potent inbibitor of DNA and RNA viruses 7.84
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 7.82
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 7.73
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 7.72
Gene expression profile of human iPSC-derived nephron progenitor cells 7.71
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 7.68
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 7.65
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 7.62
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 7.6
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 7.59
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 7.58
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 7.58
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 7.55
Transcriptomic analyssis following EHMT1/2 inhibition 7.54
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 7.54
UV_24h_GRO-Seq 7.54
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 7.52
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 7.49
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 7.47
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 7.46
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 7.42
RNA-seq of naive and primed ES cells 7.42
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 7.4
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 7.34
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 7.28
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 7.28
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 7.28
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 7.23
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 7.23
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 7.2
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 7.19
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 7.17
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 7.17
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 7.16
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 7.12
High-throughput sequencing of pluripotent cells 7.1
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 7.09
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 7.04
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 7.04
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 7.03
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 7.03
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 7.01
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 7.0
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 6.92
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 6.86
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 6.86
Stem and effector CD8 T-cells from human cancers 6.81
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 6.77
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 6.76
Cleavage Factor Im as a key regulator of 3’ UTR length 6.72
Capturing the Interactome of Newly Transcribed RNA (RICK) 6.7
Capturing the Interactome of Newly Transcribed RNA 6.7
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 6.63
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 6.51
RNA transcriptome analysis during HSV-1 infection 6.46
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 6.31
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 6.25
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 6.23
X-Ray induced DNA-Hydroxymethylation changes 6.13
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 6.05
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 6.05
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 6.03
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 6.03
The cohesin release factor WAPL restricts chromatin loop extension. 6.03
Genome-wide identification of cancer-specific alternative splicing in circRNA 5.96
Genetic-to-epigenetic Therapy for Pancreatic Cancer 5.95
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 5.91
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 5.89
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 5.87
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 5.86
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 5.86
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 5.81
Searching for target genes of miR-508/509/506/514 in HCT116 cells 5.81
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 5.8
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 5.8
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 5.8
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 5.79
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 5.78
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 5.76
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 5.75
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 5.75
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 5.72
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 5.7
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 5.69
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 5.69
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 5.67
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 5.66
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 5.65
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 5.65
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 5.64
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 5.63
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 5.62
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 5.6
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 5.59
mRNA expression in human DAOY cells 5.59
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 5.57
Targeting MTHFD2 in Acute Myeloid Leukemia 5.51
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 5.49
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 5.47
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 5.46
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 5.4
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 5.34
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 5.31
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 5.31
MYCL and EP400 are required for Max and MCPyV mediated gene activation 5.3
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 5.26
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 5.16
Expression profiling of MCF-7 cells with treatment of TCDD 5.15
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 5.15
CDK12 mediated transcriptional regulation in U2OS cells 5.1
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 5.08
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 4.98
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 4.96
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 4.96
Determination of tRNA aminoacylation levels by high throughput sequencing 4.93
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 4.82
The DPYSL2 gene connects mTOR and schizophrenia 4.8
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 4.76
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 4.69
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 4.59
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 4.51
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 4.36
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 4.34
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 4.34
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 4.27
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 4.26
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 4.26
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 4.26
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 4.23
Alagille_Nodder 4.2
RNA Seq of Alagille liver biopsies 4.2
Molecular Criteria for Defining the Naive Human Pluripotent State 4.13
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 4.13
RNA-seq analysis upon ARID1B overexpression 4.12
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 4.11
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 4.11
The transcriptome effect of overexpressing EZH2 in MCF7 4.02
An integrative analysis of non-coding regulatory DNA variations associated with autism 3.9
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 3.9
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 3.9
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 3.84
RNA Sequencing of Human iPS derived Cardiomyocytes 3.83
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 3.8
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 3.79
Exploring ILF2 regulatory genes by next-generation sequencing 3.73
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 3.68
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 3.67
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 3.59
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 3.57
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 3.51
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 3.48
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 3.48
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 3.41
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 3.4
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 3.4
Identification of renal resident macrophages across species [C1] 3.39
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 3.36
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 3.36
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 3.31
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 3.28
Transcriptome of human ILC2s; primary vs IL-1b-primed 3.26
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 3.25
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 3.21
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 3.1
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 3.1
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 3.04
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 3.01
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 3.0
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 3.0
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 3.0
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 2.95
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 2.95
RNAseq of cell lines with knocked in ESR1 mutations 2.94
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 2.93
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 2.9
RNA-seq analysis of control and Myc-induced U2OS cells 2.87
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 2.86
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 2.85
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 2.85
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 2.79
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 2.79
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 2.71
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 2.71
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 2.68
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 2.67
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 2.64
Generation and persistence of human tissue-resident memory T cells in lung transplantation 2.57
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 2.57
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 2.55
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 2.55
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 2.55
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 2.45
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 2.42
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 2.41
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 2.36
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 2.36
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 2.36
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 2.36
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 2.36
In vitro modeling of human germ cell development using pluripotent stem cells 2.31
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 2.3
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 2.3
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 2.3
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 2.26
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 2.16
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 2.13
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 2.12
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 2.12
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 2.11
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 2.08
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 2.04
Copper Regulation of HIF-1 Transcription Activity 2.03
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 2.03
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 1.9
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.88
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.88
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 1.84
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 1.84
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 1.84
Aneuploidy triggers an immune response 1.8
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 1.79
AUF-1 affected genes in human skin cells 1.76
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 1.68
High-resolution comparative analysis of great ape genomes 1.65
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.61
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.61
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 1.59
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 1.59
Effects of transcription on genome - nuclear lamina interactions 1.59
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 1.53
N6-methyladenine DNA Modification in Glioblastoma 1.52
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 1.52
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 1.45
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 1.43
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 1.3
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 1.28
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 1.26
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.23
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 1.23
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 1.17
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 1.11
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 1.1
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 1.1
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 1.08
Subtle asymmetry of gene expression in embryonic and foetal human brains 1.07
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 1.07
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 1.07
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 1.04
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.01
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 1.0
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 1.0
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.97
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.97
STX4 Over-Expression in Human islets 0.95
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.95
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.95
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.94
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.94
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.91
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.91
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.9
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.9
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.75
Transcriptomic analysis of LSD1 0.72
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.69
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 0.69
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 0.69
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.6
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.6
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 0.6
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 0.6
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 0.6
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 0.51
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 0.51
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.48
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 0.48
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 0.48
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.44
EGR1-controlled transcriptome of T HESCs 0.44
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 0.42
A code of mono-phosphorylation modulates the function of RB. 0.4
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.38
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.38
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.34
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.33
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.29
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 0.28
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.28
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.27
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.24
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.19
Modulation of nonsense-mediated decay by rapamycin 0.17
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 0.17
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.15
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.15
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.15
The role of the Calcium-Sensing receptor in colorectal cancer 0.13
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.12
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.11
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.1
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.08
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.08
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.08
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.07
SOX11 knockdown in B-ALL cell lines 0.02
MARS Seq data from human cortical organoids 0.02
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.01
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.01
Human Treg IL-12 stimulation 0.01
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 0.01
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation